Trial Profile
Testosterone undecanoate in older men with testosterone deficiency syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2013
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 05 Jan 2012 New trial record
- 01 Feb 2010 Primary endpoint 'Quality-of-life-instrument' has been met, according to BJU International.